Literature DB >> 14656913

Randomized comparison between stenting and off-pump bypass surgery in patients referred for angioplasty.

Frank Eefting1, Hendrik Nathoe, Diederik van Dijk, Erik Jansen, Jaap Lahpor, Pieter Stella, Willem Suyker, Jan Diephuis, Harry Suryapranata, Sjef Ernst, Cornelius Borst, Erik Buskens, Diederick Grobbee, Peter de Jaegere.   

Abstract

BACKGROUND: Stenting improves cardiac outcome in comparison with balloon angioplasty. Compared with conventional surgery, off-pump bypass surgery on the beating heart without cardiopulmonary bypass may reduce morbidity, hospital stay, and costs. The purpose, therefore, was to compare cardiac outcome, quality of life, and cost-effectiveness 1 year after stenting and after off-pump surgery. METHODS AND
RESULTS: Patients referred for angioplasty (n=280) were randomly assigned to stenting (n=138) or off-pump bypass surgery. At 1 year, survival free from stroke, myocardial infarction, and repeat revascularization was 85.5% after stenting and 91.5% after off-pump surgery (relative risk, 0.93; 95% CI, 0.86 to 1.02). Freedom from angina was 78.3% after stenting and 87.0% after off-pump surgery (P=0.06). Quality-adjusted lifetime was 0.82 year after stenting and 0.79 year after off-pump surgery (P=0.09). Hospital stay after the initial procedure was 1.43 and 5.77 days, respectively (P<0.01). Stenting reduced overall costs by 2933 dollars (26.2%) per patient (8276 dollars versus 11 209 dollars; P<0.01). Stenting was more cost-effective in 95% of the bootstrap estimates.
CONCLUSIONS: At 1 year, stenting was more cost-effective than off-pump surgery while maintaining comparable cardiac outcome and quality of life. Stenting rather than off-pump surgery, therefore, can be recommended as a first-choice revascularization strategy in selected patients.

Entities:  

Mesh:

Year:  2003        PMID: 14656913     DOI: 10.1161/01.CIR.0000100723.50363.2C

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

Review 1.  Coronary artery revascularization: past, present, future: part II--newer technologies.

Authors:  Anuj Gupta; James Burke; Alfred Bove
Journal:  Clin Cardiol       Date:  2006-08       Impact factor: 2.882

2.  Off-pump coronary artery bypass surgery compared with stent implantation and on-pump bypass surgery: clinical outcome and cost-effectiveness at one year.

Authors:  H M Nathoe; D van Dijk; E W L Jansen; C Borst; D E Grobbee; P P T de Jaegere
Journal:  Neth Heart J       Date:  2005-08       Impact factor: 2.380

Review 3.  Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes.

Authors:  A Bakhai; R A Hill; Y Dundar; R Dickson; T Walley
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

Review 4.  Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.

Authors:  David M Charytan; Manisha Desai; Maya Mathur; Noam M Stern; Maria M Brooks; Lukasz J Krzych; Gerhard C Schuler; Jan Kaehler; Alfredo M Rodriguez-Granillo; Whady Hueb; Barnaby C Reeves; Holger Thiele; Alfredo E Rodriguez; Piotr P Buszman; Paweł E Buszman; Rie Maurer; Wolfgang C Winkelmayer
Journal:  Kidney Int       Date:  2016-06-01       Impact factor: 10.612

5.  Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis.

Authors:  Mario Gaudino; Irbaz Hameed; Michael E Farkouh; Mohamed Rahouma; Ajita Naik; N Bryce Robinson; Yongle Ruan; Michelle Demetres; Giuseppe Biondi-Zoccai; Dominick J Angiolillo; Emilia Bagiella; Mary E Charlson; Umberto Benedetto; Marc Ruel; David P Taggart; Leonard N Girardi; Deepak L Bhatt; Stephen E Fremes
Journal:  JAMA Intern Med       Date:  2020-12-01       Impact factor: 21.873

6.  Difference in spontaneous myocardial infarction and mortality in percutaneous versus surgical revascularization trials: A systematic review and meta-analysis.

Authors:  Mario Gaudino; Antonino Di Franco; Cristiano Spadaccio; Mohamed Rahouma; N Bryce Robinson; Michelle Demetres; Stephen Fremes; Torsten Doenst
Journal:  J Thorac Cardiovasc Surg       Date:  2021-04-29       Impact factor: 5.209

7.  Cardiac revascularization--a need for independent decision-makers.

Authors:  Lindsay C H John
Journal:  J R Soc Med       Date:  2005-01       Impact factor: 18.000

8.  Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.

Authors:  Henk F van Stel; Erik Buskens
Journal:  Health Qual Life Outcomes       Date:  2006-03-25       Impact factor: 3.186

Review 9.  A review of health utilities using the EQ-5D in studies of cardiovascular disease.

Authors:  Matthew T D Dyer; Kimberley A Goldsmith; Linda S Sharples; Martin J Buxton
Journal:  Health Qual Life Outcomes       Date:  2010-01-28       Impact factor: 3.186

Review 10.  Cost-effectiveness analysis in cardiac surgery: A review of its concepts and methodologies.

Authors:  Bart S Ferket; Jonathan M Oxman; Alexander Iribarne; Annetine C Gelijns; Alan J Moskowitz
Journal:  J Thorac Cardiovasc Surg       Date:  2017-11-15       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.